As medications like Ozempic continue to rise in popularity, more details about the side effects of the drug are coming to ...

Senator Kurt Vialet pressed for more details on how the $1.5 million would be spent. Dr. Sheen explained that the Center’s ...

Medicaid plans often put up barriers around newer classes of diabetes medications that offer cardioprotection, according to a ...

Georgia Southern University graduate student Madison Procyk is reimagining insulin pump technology with a simpler, smaller, ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Ultra-processed foods, or packaged foods that contain food additives (substances that enhance food’s texture, shelf-life, ...

The cause of death has been confirmed for Michelle Trachtenberg, the 39-year-old actress who was found dead in a New York ...

Continuous glucose monitoring devices could overstate blood sugar levels, with a study revealing inconsistencies in readings compared with traditional methods.

GLP-1 and SGLT2 drugs — could significantly reduce the risk of developing dementia in life, a large new study has found.

“It’s not a dynasty. I’m not asking them to run Microsoft,” he explained. “I want to give them a chance to have their own earnings and success, be significant, and not overshadowed by ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs ...